New CRO Named to Partnership

Discussion in 'Pfizer' started by Anonymous, Apr 26, 2015 at 9:35 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest


  2. Anonymous

    Anonymous Guest

    Nothing known, but this is where the industry is headed as a whole for development. Massive outsourcing to CROs, and the jobs we know in this area of pharma today, will not exist in 3-5 years. Mostly high-level strategic planning type roles at the Sr. Manager/Director level and on up. Nothing below that, except maybe a few temporary contractors.

    I really feel bad for the 20 somethings in development. They had the ladder burned/destroyed before most could even get going in their career. What you are starting to see shake out in development are those with FT jobs and mostly above age 30 - they got in at the right time. Nothing special about them except for when they entered this field. We're going to see a real talent drain soon
     
  3. Anonymous

    Anonymous Guest

    PPD? OMG! What assholes made that decision?! Send in the CLOWNS!- (WAIT, don't bother, they're here)!
     
  4. Anonymous

    Anonymous Guest

    I don't think there are any additional projects not already outsourced that would require a 3rd CRO. PPD is probably going to replace one of the existing CRO partners. Pfizer's large scale outsourcing of R&D is a case study in the making. All of the execs in the industry are waiting for this model to finally work so they can jump on board. All of the peons who still have sponsor-side jobs in R&D are hoping that it continues to fail.
     
  5. Anonymous

    Anonymous Guest

    Not true. Pfizer leaders in clinical don't have a clue how to put together and lead a team of clinical research professionals. These leaders are confused and micromanage any CRO to death- then they replace them because "its not working". What pfizer leaders need to stop doing is making backroom deals with CROs and focus on the proper way to get the job done. CROs are not the answer... but then they have nothing of real value in the pipeline to research, so...

    Also no one who does serious clinical research is looking to Pfizer to "jump on the band wagon". The PFE band is tone deaf and the wagon has one wheel...
     
  6. Anonymous

    Anonymous Guest

    PRXL perform badly so likely to get fired - PPD might be the replacement. CROs sell process, not quality.
     
  7. Anonymous

    Anonymous Guest

    And dirt cheap labor. Go ask anyone at PXL about the layoffs last year and how they were replaced by dirt cheap dumb as can be and uneducated eastern european, APAC and LATAM teams. They still charge the sponsor the same $$ and keep the American front-facers, but the grunt work is now done in foreign white collar sweat shops. Anything to push the margins up while CROs bid them lower and lower.
     
  8. Anonymous

    Anonymous Guest

    Outsourcing to foreign sweat shops is ongoing in many other parts of the company too, like IT and Regulatory. Hard to have any sympathy for Americans, though. When was the last time we voted to support good jobs? That just doesn't happen. We always vote Republican so corporations can make bigger profits and more money can go to the rich. A classic case of natural selection at work.
     
  9. #9 Anonymous, May 16, 2015 at 10:06 AM
    Last edited by a moderator: Oct 18, 2015 at 10:40 AM
    Anonymous

    Anonymous Guest

    But if vote democrat and as a result you see higher taxes and more tighter regulations, making it far more expensive to operate in the US than ever before, then you would have the same result more or less.Case in point look at the jobs leaving CA for TX.

    When it comes to cheaper labor foreign labor, it doesn't matter what the policy is and who originates it, there is one common denominator and it is access to cheap foreign labor and you can thank the internet, VPN connections, cloud based SaaS-like systems and a world that has closed the gap in skills juusssttt enough to make it all happen.

    To answer the original question, yes, there will be more outsourcing. Probably more early stage now as opposed to the later stage outsourcing that had been occurring these last several years.